LDL-C target attainment

Biomarker

1 paper3 findings

  • Humans1

Interventions

2

Statin dose escalation

no changein humans1

1 study
  1. Statin dose escalation has no effect on LDL-C target attainment in humans.

    Humansin people with HIV ≥40 yearsn = 588

    LDL-C target achievement in people living with HIV: impact of combination lipid-lowering therapy. A retrospective cohort analysis

    AIDS (London, England)19 Aug 2026

More on Statin dose escalation

Combination lipid-lowering therapy

upin humans1OR 5.7

1 study
  1. Combination lipid-lowering therapy increases LDL-C target attainment in humans (OR 5.7, 95% CI 3.7-9.0).

    Humansin people with HIV ≥40 yearsn = 588

    LDL-C target achievement in people living with HIV: impact of combination lipid-lowering therapy. A retrospective cohort analysis

    AIDS (London, England)19 Aug 2026

More on Combination lipid-lowering therapy

Associations

1

Diabetes

upin humans1

1 study
  1. Diabetes is associated with LDL-C target attainment in humans.

    Humansin people with HIV ≥40 yearsn = 588

    LDL-C target achievement in people living with HIV: impact of combination lipid-lowering therapy. A retrospective cohort analysis

    AIDS (London, England)19 Aug 2026

More on Diabetes

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 3Sep 2026: 1Oct 2026: 05 in 12 months